Market Research Report - 251494
European Alzheimer's Disease Medication Market
|Published by||Frost & Sullivan|
The key objective of this research service is to study the European Alzheimer's disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments. It also aims to provide valuable insights on the potential drug candidates in the pipeline and analyse the competitive landscape with respect to the key existing market participants and promising companies in the future. Revenue forecasts of total market as well as key five European countries is also provided.